Genentech, Inc.

This study allowed people with certain cancers (ovarian, basal cell, or colorectal) who had already shown benefit from the drug vismodegib in an earlier study to keep receiving it. The main goal was to track side effects and see how many people had to stop treatment due to them. …

This early-phase trial tested an experimental drug called cevostamab in 355 people with multiple myeloma that had returned or stopped responding to other treatments. The main goal was to check the drug's safety and find the right dose. While not a cure, the study aims to help con…

This study tested the drug ocrelizumab in 179 Black and Hispanic patients with relapsing multiple sclerosis. The goal was to see how well the drug controls disease activity and nerve damage over 48 weeks. Participants received ocrelizumab and were monitored for relapses, disabili…

This study tested whether adding tiragolumab to the standard immunotherapy atezolizumab works better than atezolizumab alone for people with advanced non-small cell lung cancer who had not received prior treatment. 135 participants received either the combination or a placebo plu…

This study tested an experimental drug called mosunetuzumab, given alone or with another drug (atezolizumab), in 713 people with B-cell non-Hodgkin lymphoma or chronic lymphocytic leukemia that had come back or stopped responding to prior treatments. The goal was to find the safe…

This study looked at how the body processes a single dose of the drug divarasib in people with different levels of liver function. It included 31 adults with healthy livers or mild to severe liver problems. The goal was to measure drug levels in the blood and check for side effec…

This study looked at how safe and tolerable an injection of immunoglobulin G (a type of antibody) is when given under the skin. 82 healthy adults received the injection under different conditions to see how they felt and if there were any side effects. The goal was not to treat a…